J G Lanham, G R Hughes. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antimalarials/adverse effectsAntimalarials/metabolismAntimalarials/therapeutic useBinding Sites/drug effectsChloroquine/adverse effectsChloroquine/metabolismChloroquine/therapeutic useCorneal Diseases/chemically inducedDose-Response Relationship, DrugFemaleHumansHydroxychloroquine/adverse effectsHydroxychloroquine/metabolismHydroxychloroquine/therapeutic useImmune Tolerance/drug effectsInflammation/drug therapyKineticsLupus Erythematosus, Discoid/drug therapyLupus Erythematosus, Systemic/complicationsLupus Erythematosus, Systemic/drug therapyNucleoproteins/metabolismPhotosensitivity Disorders/drug therapyPhotosensitivity Disorders/etiologyPregnancyQuinacrine/therapeutic useRetinal Diseases/chemically inducedRetinal Pigments/toxicitySkin Diseases/drug therapySkin Diseases/etiologyVirus Replication/drug effects
Substances： See more » AntimalarialsNucleoproteinsRetinal PigmentsHydroxychloroquineChloroquineQuinacrine
Year: 1982 PMID： 6749400
Source DB: PubMed Journal: Clin Rheum Dis ISSN： 0307-742X